FVCSX | JVMRX | FVCSX / JVMRX | |
Total Expense Ratio | 1.84 | 0.75 | 245% |
Annual Report Gross Expense Ratio | 1.84 | 0.76 | 242% |
Fund Existence | 24 years | 14 years | - |
Gain YTD | 0.295 | 8.686 | 3% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.7B | 22.9B | 7% |
Annual Yield % from dividends | 0.46 | 0.88 | 52% |
Returns for 1 year | -10.71 | 0.66 | -1,623% |
Returns for 3 years | 8.54 | 20.98 | 41% |
Returns for 5 years | 55.18 | 57.59 | 96% |
Returns for 10 years | -5.03 | 50.21 | -10% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
KLXY | 25.67 | 0.90 | +3.63% |
KraneShares Global Luxury Index ETF | |||
IWB | 350.15 | 1.63 | +0.47% |
iShares Russell 1000 ETF | |||
EDOW | 39.11 | 0.16 | +0.42% |
First Trust Dow 30 Equal Weight ETF | |||
FMED | 24.15 | 0.06 | +0.26% |
Fidelity Disruptive Medicine ETF | |||
EDIV | 38.79 | -0.21 | -0.54% |
SPDR® S&P Emerging Markets Dividend ETF |